These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 9809962)

  • 1. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death.
    Haider AW; Larson MG; Benjamin EJ; Levy D
    J Am Coll Cardiol; 1998 Nov; 32(5):1454-9. PubMed ID: 9809962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of increased left ventricular mass index to mortality and sudden death in patients with stable coronary heart disease (from the Heart and Soul Study).
    Turakhia MP; Schiller NB; Whooley MA
    Am J Cardiol; 2008 Nov; 102(9):1131-5. PubMed ID: 18940278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymptomatic ventricular arrhythmias and mortality risk in subjects with left ventricular hypertrophy.
    Bikkina M; Larson MG; Levy D
    J Am Coll Cardiol; 1993 Oct; 22(4):1111-6. PubMed ID: 8409049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study.
    Verma A; Meris A; Skali H; Ghali JK; Arnold JM; Bourgoun M; Velazquez EJ; McMurray JJ; Kober L; Pfeffer MA; Califf RM; Solomon SD
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):582-91. PubMed ID: 19356485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of left ventricular dilatation and hypertrophy with chronotropic incompetence in the Framingham Heart Study.
    Lauer MS; Larson MG; Evans JC; Levy D
    Am Heart J; 1999 May; 137(5):903-9. PubMed ID: 10220640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left Ventricular Geometry Determines Prognosis and Reverse J-Shaped Relation Between Blood Pressure and Mortality in Ischemic Stroke Patients.
    Park CS; Park JB; Kim Y; Yoon YE; Lee SP; Kim HK; Kim YJ; Cho GY; Sohn DW; Lee SH
    JACC Cardiovasc Imaging; 2018 Mar; 11(3):373-382. PubMed ID: 28624400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy.
    Olivotto I; Gistri R; Petrone P; Pedemonte E; Vargiu D; Cecchi F
    J Am Coll Cardiol; 2003 Jan; 41(2):315-21. PubMed ID: 12535828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes in atrial fibrillation patients with and without left ventricular hypertrophy when treated with a lenient rate-control or rhythm-control strategy.
    Badheka AO; Shah N; Grover PM; Patel NJ; Chothani A; Mehta K; Singh V; Deshmukh A; Savani GT; Rathod A; Panaich SS; Patel N; Arora S; Bhalara V; Coffey JO; Mitrani RD; Halperin JL; Viles-Gonzalez JF
    Am J Cardiol; 2014 Apr; 113(7):1159-65. PubMed ID: 24507168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.
    Wachtell K; Okin PM; Olsen MH; Dahlöf B; Devereux RB; Ibsen H; Kjeldsen SE; Lindholm LH; Nieminen MS; Thygesen K
    Circulation; 2007 Aug; 116(7):700-5. PubMed ID: 17664372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left Ventricular Mass at MRI and Long-term Risk of Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Kawel-Boehm N; Kronmal R; Eng J; Folsom A; Burke G; Carr JJ; Shea S; Lima JAC; Bluemke DA
    Radiology; 2019 Oct; 293(1):107-114. PubMed ID: 31453766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular hypertrophy reclassification and death: application of the Recommendation of the American Society of Echocardiography/European Association of Echocardiography.
    Barbieri A; Bursi F; Mantovani F; Valenti C; Quaglia M; Berti E; Marino M; Modena MG
    Eur Heart J Cardiovasc Imaging; 2012 Jan; 13(1):109-17. PubMed ID: 21979990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular hypertrophy on long-term cardiovascular outcomes in patients with ST-elevation myocardial infarction.
    Park JS; Shin JS; Lee YH; Seo KW; Choi BJ; Choi SY; Yoon MH; Hwang GS; Tahk SJ; Shin JH
    Clin Exp Hypertens; 2015; 37(8):674-9. PubMed ID: 26151825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of left ventricular mass severity according to the classification proposed by the American Society of Echocardiography/European Association of Echocardiography.
    Barbieri A; Bursi F; Mantovani F; Valenti C; Quaglia M; Berti E; Marino M; Modena MG
    J Am Soc Echocardiogr; 2011 Dec; 24(12):1383-91. PubMed ID: 21975437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albuminuria predicts cardiovascular events independently of left ventricular mass in hypertension: a LIFE substudy.
    Olsen MH; Wachtell K; Bella JN; Palmieri V; Gerdts E; Smith G; Nieminen MS; Dahlöf B; Ibsen H; Devereux RB
    J Hum Hypertens; 2004 Jun; 18(6):453-9. PubMed ID: 15085167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients.
    Bang CN; Gerdts E; Aurigemma GP; Boman K; de Simone G; Dahlöf B; Køber L; Wachtell K; Devereux RB
    Circ Cardiovasc Imaging; 2014 May; 7(3):422-9. PubMed ID: 24723582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular mass and the risk of sudden cardiac death: a population-based study.
    Laukkanen JA; Khan H; Kurl S; Willeit P; Karppi J; Ronkainen K; Di Angelantonio E
    J Am Heart Assoc; 2014 Nov; 3(6):e001285. PubMed ID: 25376188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular architecture and survival in African-Americans free of coronary heart disease (from the Atherosclerosis Risk in Communities [ARIC] study).
    Taylor HA; Penman AD; Han H; Dele-Michael A; Skelton TN; Fox ER; Benjamin EJ; Arnett DK; Mosley TH
    Am J Cardiol; 2007 May; 99(10):1413-20. PubMed ID: 17493471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrocardiographic Left Ventricular Hypertrophy as a Predictor of Cardiovascular Disease Independent of Left Ventricular Anatomy in Subjects Aged ≥65 Years.
    Leigh JA; O'Neal WT; Soliman EZ
    Am J Cardiol; 2016 Jun; 117(11):1831-5. PubMed ID: 27067620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of left ventricular mass change during treatment of hypertension.
    Devereux RB; Wachtell K; Gerdts E; Boman K; Nieminen MS; Papademetriou V; Rokkedal J; Harris K; Aurup P; Dahlöf B
    JAMA; 2004 Nov; 292(19):2350-6. PubMed ID: 15547162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.